STX17 and melanoma: We have previously demonstrated that the causative mutation for the Grey horse phenotype encompassing the dramatically increased risk of melanoma development is a 4.6 kb duplication in intron 6 of Syntaxin 17 (STX17) ([17]; referred to as Grey mutation thereafter).